Standout Papers

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an internat... 2012 2026 2016 2021 2.0k
  1. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial (2012)
    Axel Grothey, Eric Van Cutsem et al. The Lancet

Immediate Impact

3 by Nobel laureates 20 from Science/Nature 75 standout
Sub-graph 1 of 21

Citing Papers

Tumour vasculature at single-cell resolution
2024 StandoutNature
Colorectal cancer
2024 Standout
25 intermediate papers

Works of Dirk Laurent being referenced

Time profile of adverse events (AEs) from regorafenib (REG) treatment for metastatic colorectal cancer (mCRC) in the phase III CORRECT study.
2013
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
2012 Standout
and 8 more

Author Peers

Author Last Decade Papers Cites
Dirk Laurent 2896 1450 966 1501 76 4.5k
Francesca Molinari 3036 1508 1132 1475 52 4.6k
Ferry A.L.M. Eskens 2813 1446 1209 2570 159 6.2k
Bruce J. Giantonio 3309 1541 743 1266 123 4.9k
Allen Lee Cohn 4629 2314 1220 1500 158 6.7k
Mark Kozloff 3140 1639 696 1282 124 4.6k
Piercarlo Saletti 4167 2040 1083 1005 74 5.4k
István Láng 5134 2265 1935 1085 113 6.8k
Markus Borner 2945 1806 815 1765 125 5.4k
Jae Kyung Roh 4123 1774 846 1089 151 5.7k
Shenhong Wu 2882 1652 433 1422 96 5.3k

All Works

Loading papers...

Rankless by CCL
2026